SI1114166T1 - Method for down-regulating osteoprotegerin ligand activity - Google Patents

Method for down-regulating osteoprotegerin ligand activity

Info

Publication number
SI1114166T1
SI1114166T1 SI9930789T SI9930789T SI1114166T1 SI 1114166 T1 SI1114166 T1 SI 1114166T1 SI 9930789 T SI9930789 T SI 9930789T SI 9930789 T SI9930789 T SI 9930789T SI 1114166 T1 SI1114166 T1 SI 1114166T1
Authority
SI
Slovenia
Prior art keywords
ligand activity
osteoprotegerin ligand
regulating
regulating osteoprotegerin
activity
Prior art date
Application number
SI9930789T
Other languages
English (en)
Slovenian (sl)
Inventor
Torben Halkier
Jesper Haaning
Original Assignee
Pharmexa A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmexa A/S filed Critical Pharmexa A/S
Priority claimed from PCT/DK1999/000481 external-priority patent/WO2000015807A1/fr
Publication of SI1114166T1 publication Critical patent/SI1114166T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI9930789T 1998-09-15 1999-09-13 Method for down-regulating osteoprotegerin ligand activity SI1114166T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA199801164 1998-09-15
US10289698P 1998-10-02 1998-10-02
PCT/DK1999/000481 WO2000015807A1 (fr) 1998-09-15 1999-09-13 Procede de regulation negative de l'activite des ligands d'osteoprotegerine
EP99942778A EP1114166B1 (fr) 1998-09-15 1999-09-13 Procede de regulation negative de l'activite des ligands d'osteoprotegerine

Publications (1)

Publication Number Publication Date
SI1114166T1 true SI1114166T1 (en) 2005-10-31

Family

ID=34527328

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930789T SI1114166T1 (en) 1998-09-15 1999-09-13 Method for down-regulating osteoprotegerin ligand activity

Country Status (3)

Country Link
EP (1) EP1541587A3 (fr)
DK (1) DK1114166T3 (fr)
SI (1) SI1114166T1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1237764B (it) * 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
DK96493D0 (da) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
EP1114864B9 (fr) * 1996-12-13 2013-05-08 Schering Corporation Antigènes de surface de cellules de mammifères
EP2371962A3 (fr) * 1996-12-23 2011-12-21 Immunex Corporation Activateur du récepteur de NF-KAPPA B, récepteur membre de la superfamille des récepteurs de TNF
RO128635A2 (ro) * 1997-04-16 2013-07-30 Amgen Inc. Anticorp sau fragment al acestuia care se leagă la opgbp şi utilizarea acestuia, utilizarea unei forme solubile de odar, şi metodă de identificare a unui compus care descreşte activitatea opgbp

Also Published As

Publication number Publication date
EP1541587A3 (fr) 2007-06-20
DK1114166T3 (da) 2005-08-01
EP1541587A2 (fr) 2005-06-15

Similar Documents

Publication Publication Date Title
HUP0103578A3 (en) Method for down-regulating osteoprotegerin ligand activity
AU2869799A (en) Diagnostic method for analyzing emboli
HUP0103625A3 (en) Method for regenerating catalysts
HK1029208A1 (en) Computer operating method
EP1103812A4 (fr) Procede de determination d'hemoglobines
GB9809414D0 (en) Method
EP1304573A4 (fr) Methode de criblage d'un ligand dote d'une activite biologique
IL145786A0 (en) Method for down-regulating il5 activity
IL140951A0 (en) Method for analyzing cuts
GB9809776D0 (en) Method
GB2332596A9 (en) Method for predicting interference
GB9814055D0 (en) Method
GB9810722D0 (en) Method
GB9819764D0 (en) Method
SI1114166T1 (en) Method for down-regulating osteoprotegerin ligand activity
GB9802475D0 (en) Method
GB9817266D0 (en) Method
GB2336506B (en) Method and system for interference reduction
EP1063000A4 (fr) PROCEDE D'ELIMINATION DE NOx
IL140058A0 (en) Methods for inhibiting tef-3 activity
GB0026109D0 (en) An analysis method
GB9809780D0 (en) Method
GB9809782D0 (en) Method
GB9804355D0 (en) Method
GB9807772D0 (en) Test method